These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 1388019)

  • 1. Coagulation and fibrinolysis in cancer.
    Heimburger N; Pâques EP; Römisch J
    Behring Inst Mitt; 1992 Apr; (91):169-82. PubMed ID: 1388019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathophysiology and clinical aspects of fibrinolysis and inhibition of coagulation. Experimental and clinical studies with special reference to women on oral contraceptives and selected groups of thrombosis prone patients.
    Jespersen J
    Dan Med Bull; 1988 Feb; 35(1):1-33. PubMed ID: 3277796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathways of coagulation/fibrinolysis activation in malignancy.
    Zacharski LR; Wojtukiewicz MZ; Costantini V; Ornstein DL; Memoli VA
    Semin Thromb Hemost; 1992 Jan; 18(1):104-16. PubMed ID: 1574711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.
    Idell S
    Crit Care Med; 2003 Apr; 31(4 Suppl):S213-20. PubMed ID: 12682443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tumor metastasis and the fibrinolytic system].
    Yamamura M; Yamamoto M
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1246-54. PubMed ID: 2730023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The physiology of hemostasis: plasma and tissue factors in coagulation and fibrinolysis].
    François P; Verstraeten L; Dinant JP
    J Pharm Belg; 1989; 44(4):308-14. PubMed ID: 2691642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haemostasis in oral surgery--the possible pathogenetic implications of oral fibrinolysis on bleeding. Experimental and clinical studies of the haemostatic balance in the oral cavity, with particular reference to patients with acquired and congenital defects of the coagulation system.
    Sindet-Pedersen S
    Dan Med Bull; 1991 Dec; 38(6):427-43. PubMed ID: 1802633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activated coagulation factors in human malignant effusions and their contribution to cancer cell metastasis and therapy.
    Gieseler F; Lühr I; Kunze T; Mundhenke C; Maass N; Erhart T; Denker M; Beckmann D; Tiemann M; Schulte C; Dohrmann P; Cavaillé F; Godeau F; Gespach C
    Thromb Haemost; 2007 Jun; 97(6):1023-30. PubMed ID: 17549306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The haemostatic balance in groups of thrombosis-prone patients. With particular reference to fibrinolysis in patients with myocardial infarction.
    Gram J
    Dan Med Bull; 1990 Jun; 37(3):210-34. PubMed ID: 2192835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Development and dissemination of malignant tumors and hemostasis].
    Kher A; Hilgard P
    Pathol Biol (Paris); 1982 Dec; 30(10):861-7. PubMed ID: 6760066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hemostatic mechanisms and malignant tumors].
    Kase F; Pospísil J; Hlousková D
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(6):809-30. PubMed ID: 2419210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview of the postulated mechanisms linking cancer and thrombosis.
    ten Cate H; Falanga A
    Pathophysiol Haemost Thromb; 2008; 36(3-4):122-30. PubMed ID: 19176985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of proteases in the growth, invasion and spread of cancer cells].
    Buø L; Aasen AO; Karlsrud TS; Johansen HT; Sivertsen SM
    Tidsskr Nor Laegeforen; 1990 Nov; 110(29):3753-6. PubMed ID: 2274946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmin in pericellular proteolysis and cellular invasion.
    Kramer MD; Reinartz J; Brunner G; Schirrmacher V
    Invasion Metastasis; 1994-1995; 14(1-6):210-22. PubMed ID: 7657514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Coagulation and fibrinolysis parameters in disseminated intravascular coagulation (DIC)].
    Nakagawa T; Saito H; Watanabe Y; Sato M; Murakawa E
    Rinsho Byori; 1991 Mar; 39(3):309-14. PubMed ID: 1828842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Development and dissemination of malignant tumors, and hemostasis].
    Kher A; Hilgard P
    Sem Hop; 1983 Apr; 59(17):1348-54. PubMed ID: 6306819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes in the blood coagulation system and fibrinolysis during growth and metastasis of malignant neoplasms].
    Bergut FA
    Sov Med; 1976 Apr; (4):45-51. PubMed ID: 790595
    [No Abstract]   [Full Text] [Related]  

  • 18. Antimetastatic agents. II. Summary of the interactions of tumor cells with blood coagulation factors, platelets, fibrinolytic factors, and inflammatory cells and their soluble mediators: potential for therapeutic interventions.
    Rickles FR; Hancock WW
    Semin Thromb Hemost; 1988 Jan; 14(1):126-32. PubMed ID: 3353730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemostasis and cancer.
    Francis JL
    Med Lab Sci; 1989 Oct; 46(4):331-46. PubMed ID: 2693872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Disseminated intravascular coagulations].
    Amstutz P; Moyo JS
    Cah Anesthesiol; 1996; 44(3):219-28. PubMed ID: 9005011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.